title: Amphipathic polymer-mediated uptake of trehalose for dimethyl sulfoxide-free human cell cryopreservation.
abstract: For stem cell therapy to become a routine reality, one of the major challenges to overcome is their storage and transportation. Currently this is achieved by cryopreserving cells utilising the cryoprotectant dimethyl sulfoxide (Me2SO). Me2SO is toxic to cells, leads to loss of cell functionality, and can produce severe side effects in patients. Potentially, cells could be frozen using the cryoprotectant trehalose if it could be delivered into the cells at a sufficient concentration. The novel amphipathic membrane permeabilising agent PP-50 has previously been shown to enhance trehalose uptake by erythrocytes, resulting in increased cryosurvival. Here, this work was extended to the nucleated human cell line SAOS-2. Using the optimum PP-50 concentration and media osmolarity, cell viability post-thaw was 60 ± 2%. In addition, the number of metabolically active cells 24h post-thaw, normalised to that before freezing, was found to be between 103 ± 4% and 91 ± 5%. This was found to be comparable to cells frozen using Me2SO. Although reduced (by 22 ± 2%, p=0.09), the doubling time was found not to be statistically different to the non-frozen control. This was in contrast to cells frozen using Me2SO, where the doubling time was significantly reduced (by 41 ± 4%, p=0.004). PP-50 mediated trehalose delivery into cells could represent an alternative cryopreservation protocol, suitable for research and therapeutic applications.
authors.affiliation: Department of Chemical Engineering and Biotechnology, University of Cambridge, New Museum Site, Pembroke Street, Cambridge CB2 3RA, UK. Electronic address: dmcs2@cam.ac.uk.
authors.forename: Duncan M C
authors.initials: DM
authors.lastname: Sharp
authors.forename: Andrew
authors.initials: A
authors.lastname: Picken
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Morris
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Hewitt
authors.forename: Karen
authors.initials: K
authors.lastname: Coopman
authors.forename: Nigel K H
authors.initials: NK
authors.lastname: Slater
mesh_terms: D002460:Cell Line; D002463:Cell Membrane Permeability / Q000187:drug effects*; D002470:Cell Survival; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000378:metabolism*; D006801:Humans; D011108:Polymers / Q000737:chemistry / Q000378:metabolism*; D014199:Trehalose / Q000378:metabolism*
chemical_list: D003451:Cryoprotective Agents; D011108:Polymers; D014199:Trehalose
keywords: Biopolymer; Cryopreservation; PP-50; SAOS-2; Trehalose
references.citation: Cryobiology. 2011 Aug;63(1):26-31
references.pmid: 21530502
references.citation: Bone Marrow Transplant. 2005 Oct;36(7):601-3
references.pmid: 16044141
references.citation: Nature. 2013 Jul 25;499(7459):481-4
references.pmid: 23823721
references.citation: Cancer Res. 2001 Jun 15;61(12):4756-60
references.pmid: 11406548
references.citation: In Vitro Cell Dev Biol Anim. 2011 Mar;47(3):210-7
references.pmid: 21191664
references.citation: J Cell Physiol. 1988 Jun;135(3):443-50
references.pmid: 3397386
references.citation: Cell Tissue Bank. 2009 Nov;10(4):341-4
references.pmid: 19381873
references.citation: Purinergic Signal. 2005 Sep;1(3):219-27
references.pmid: 18404507
references.citation: Stem Cells. 2010 Apr;28(4):674-86
references.pmid: 20135682
references.citation: Methods Cell Biol. 2008;86:101-19
references.pmid: 18442646
references.citation: Biomaterials. 2009 Apr;30(10):1954-61
references.pmid: 19138797
references.citation: Epigenetics. 2012 Jun 1;7(6):635-51
references.pmid: 22507896
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7882-7
references.pmid: 8755571
references.citation: Nat Biotechnol. 2000 Feb;18(2):163-7
references.pmid: 10657121
references.citation: J Biomater Sci Polym Ed. 2010;21(12):1573-88
references.pmid: 20537242
references.citation: Stem Cells. 2005 May;23(5):681-8
references.pmid: 15849175
references.citation: Cancer Res. 1987 Sep 15;47(18):4961-6
references.pmid: 3040234
references.citation: PLoS One. 2010 Sep 01;5(9):
references.pmid: 20824143
references.citation: Cell Tissue Bank. 2012 Jun;13(2):203-15
references.pmid: 21394484
references.citation: Cancer Res. 2012 Jun 15;72(12):2957-69
references.pmid: 22505653
references.citation: Biotechnol Bioeng. 2004 Nov 5;88(3):299-312
references.pmid: 15486934
references.citation: Br J Cancer. 2003 Jan 13;88(1):125-31
references.pmid: 12556971
references.citation: Biotechnol Bioeng. 2003 Jun 5;82(5):525-32
references.pmid: 12652476
references.citation: Biomaterials. 2011 Jul;32(19):4443-9
references.pmid: 21421265
references.citation: Comp Biochem Physiol A Mol Integr Physiol. 2001 Oct;130(3):411-20
references.pmid: 11913454
references.citation: Glycobiology. 2012 Jan;22(1):123-33
references.pmid: 21852258
references.citation: Infect Immun. 1999 Mar;67(3):1045-9
references.pmid: 10024541
references.citation: Biomaterials. 2010 Aug;31(23):6096-103
references.pmid: 20471082
references.citation: Cryo Letters. 2011 Jan-Feb;32(1):81-8
references.pmid: 21468457
references.citation: Cryobiology. 2006 Oct;53(2):194-205
references.pmid: 16839540
references.citation: Stem Cells Dev. 2004 Jun;13(3):295-305
references.pmid: 15186725
references.citation: Biotechnol Prog. 2010 Nov-Dec;26(6):1635-43
references.pmid: 20572296
references.citation: Cytotherapy. 2013 Jan;15(1):2-8
references.pmid: 23260081